Navigation Links
Global Antibacterial Drugs Market 2015-2019 - Key Vendors are Allergan, GlaxoSmithKline, Merck, Novartis, Pfizer & Teva Pharmaceuticals
Date:12/8/2015

DUBLIN, December 8, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/6kjtgs/global) has announced the addition of the "Global Antibacterial Drugs Market 2015-2019" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The availability of funding for the development of drugs used in the treatment of diseases caused by drug resistant bacteria is providing an encouragement for more manufacturers to enter the market. Also, the strategic alliances formed between the vendors help in increased penetration of the drugs in the market and increase market share.

According to the report, the special regulatory designations provided for the development of antibiotic drugs is one of the major drivers for the growth of the market. The Generating Antibiotics Incentives Now (GAIN) Act by US FDA provides QIDP designation for pipeline molecules. This designation helps in the faster development of drugs along with eligibility for priority reviews for NDA.

Further, the report states that the development of multidrug-resistant microbes due to the irrational use of antibacterial drugs increases the severity of the infections often leading to the death of the individual. This is affecting market growth as mortality rates are increasing.

Key questions answered in this report: 

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the Key Market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Key Topics Covered: 

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Market research methodology

PART 04: Introduction 

PART 05: Antibacterial Overview 

PART 06: Pipeline analysis 

PART 07: Antimicrobial resistance 

PART 08: Legislation relating to antibiotic use in the US 

PART 09: Market landscape

PART 10: Market segmentation by chemical class 

PART 11: Market segmentation by drug origin 

PART 12: Market segmentation by mechanism of action 

PART 13: Market segmentation by spectrum of activity 

PART 14: Geographical segmentation 

PART 15: Market drivers 

PART 16: Impact of drivers 

PART 17: Market challenges 

PART 18: Impact of drivers and challenges 

PART 19: Market trends 

PART 20: Vendor landscape 

PART 21: Key vendor analysis 

Key vendors: 

  • Allergan
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Pfizer
  • Teva Pharmaceuticals

Other Prominent Vendors: 

  • Abbott
  • Achaogen
  • Actelion
  • AmpliPhi Biosciences
  • Aspen Pharmacare
  • Astellas
  • AstraZeneca
  • Aurobindo Pharma
  • Baxter
  • Basilea Pharmaceuticals
  • Bayer
  • Biocon
  • Bristol-Myers Squibb
  • Cempra
  • Cipher Pharmaceuticals
  • Corden Pharma
  • Cornerstone Therapeutics
  • Eli Lilly
  • Exoxemis
  • F. Hoffmann-La Roche
  • Flynn Pharma
  • Hospira
  • Incepta Pharmaceuticals
  • InSite Vision
  • Insmed Incorporated
  • Johnson & Johnson
  • KaloBios Pharmaceuticals
  • Kyorin Pharmaceutical
  • Lupin Pharmaceuticals
  • Lytix Biopharma
  • Melinta Therapeutics
  • Mylan
  • Nektar
  • Orchid Pharma
  • Par Pharmaceutical
  • Paratek Pharmaceuticals
  • Pernix Therapeutics
  • PTC Therapeutics
  • RedHill Biopharma
  • Sagent Pharmaceuticals
  • Sanofi
  • Shionogi
  • Starpharma
  • Sun Pharmaceutical
  • Symbiomix
  • Takeda Pharma
  • Tetraphase Pharmaceuticals
  • Theravance Biopharma
  • The Medicines Company
  • Valneva
  • Wockhardt Global Solutions

For more information visit http://www.researchandmarkets.com/research/6kjtgs/global

About Research and Markets 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Spine Surgery Market 2015-2019 - Key Vendors are DuPuy Synthes, Medtronic, NuVasive, Stryker & Zimmer
2. La Global Wellness Summit detecta los diez cambios clave para el futuro del bienestar
3. Global Neuroprotection Market Report 2015 - 500 Products Have Been Investigated for Neuroprotective Effects
4. Global Coronary Artery Disease Treatment Devices Market 2015-2019 - Key Vendors are Abbott Vascular, Boston Scientific, Medtronic & Terumo
5. Novartis drug PKC412 (midostaurin) improves overall survival by 23% in global Phase III study of AML patients with FLT3 mutations
6. Global Proteomics Technologies, Markets and Companies Projections to 2019 & 2024
7. The mHealth Solutions Market is Poised to Reach USD 59.15 Billion by 2020 According to, mHealth Solutions Market by Connected Devices & Apps Services - Global Forecast to 2020
8. Global Cervical Cancer Vaccine Market to Cross US$ 1.6 billion by 2020 Says Pharmaion
9. Growing Geriatric Population to Boost Global Enteric Feeding Devices Market to US$3.1 bn by 2019: Transparency Market Research
10. Global Hearing Aids Market 2015-2020 - Market Opportunities and Forecasts for the $8.3 Billion Industry
11. Global Acne Drugs Market 2016-2020 - Key Vendors are Allergan, Galderma, Stiefel & Valeant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
Breaking Medicine Technology:
(Date:5/26/2017)... Plano, Texas (PRWEB) , ... May 26, 2017 , ... ... Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita ... , “We are pleased to be the first in Arkansas to introduce the ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... ... Water damage to the flooring of several classrooms at The Fort Lee Elementary ... number of critical issues to address before students could return to classes. , First, ... no disruption to class schedules. Second, the project had to comply with New Jersey ...
Breaking Medicine News(10 mins):